Gastric cancer, Helicobacter pylori infection and other risk factors

被引:60
作者
Fuccio, Lorenzo [1 ]
Eusebi, Leonardo Henry [1 ]
Bazzoli, Franco [1 ]
机构
[1] Univ Bologna, Dept Internal Med & Gastroenterol, Policlinico S. Orsola,Via Massarenti 9, E-40138 Bologna, Italy
关键词
Helicobacter pylori; Eradication treatment; Diet; Gastric cancer; PACIFIC CONSENSUS GUIDELINES; NITRIC-OXIDE SYNTHASE; STOMACH-CANCER; FAMILY-HISTORY; CYCLOOXYGENASE-2; EXPRESSION; VACUOLATING CYTOTOXIN; ERADICATION; ASSOCIATION; CAGA; MORTALITY;
D O I
10.4251/wjgo.v2.i9.342
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Gastric cancer incidence is declining. However, it is too early to consider this neoplastic disease as rare and the worldwide mortality rate still remains high. Several risk factors have been identified for non-cardia gastric cancer and primary prevention is feasible since most of the risk factors can be removed. Helicobacter pylori eradication treatment reduces but does not abolish gastric cancer risk. Indeed, gastric cancer is a multifactorial disease and removing one factor does not therefore prevent all cases. Endoscopic surveillance is still needed, especially in subjects at higher risk. The definition of high-risk patients will be the future challenge as well as identifying the best surveillance strategy for such patients. (C) 2010 Baishideng. All rights reserved.
引用
收藏
页码:342 / 347
页数:6
相关论文
共 67 条
  • [1] [Anonymous], 2003, WHO TECHN REP SER
  • [2] [Anonymous], 2003, WORLD CANC REPORT
  • [3] [Anonymous], 1997, FOOD NUTR PREV CANC
  • [4] Citrus fruit intake and stomach cancer risk: a quantitative systematic review
    Bae, Jong-Myon
    Lee, Eun Ja
    Guyatt, Gordon
    [J]. GASTRIC CANCER, 2008, 11 (01) : 23 - 32
  • [5] Antioxidant supplements for prevention of gastrointestinal cancers: a systematic review and meta-analysis
    Bjelakovic, G
    Nikolova, D
    Simonetti, RG
    Gluud, C
    [J]. LANCET, 2004, 364 (9441) : 1219 - 1228
  • [6] Brenner H, 2000, CANCER, V88, P274, DOI 10.1002/(SICI)1097-0142(20000115)88:2<274::AID-CNCR5>3.0.CO
  • [7] 2-9
  • [8] Germline E-cadherin mutations in hereditary diffuse gastric cancer: assessment of 42 new families and review of genetic screening criteria
    Brooks-Wilson, AR
    Kaurah, P
    Suriano, G
    Leach, S
    Senz, J
    Grehan, N
    Butterfield, YSN
    Jeyes, J
    Schinas, J
    Bacani, J
    Kelsey, M
    Ferreira, P
    MacGillivray, B
    Macleod, P
    Micek, M
    Ford, J
    Foulkes, W
    Australie, K
    Greenberg, C
    LaPointe, M
    Gilpin, C
    Nikkel, S
    Gilchrist, D
    Hughes, R
    Jackson, CE
    Monaghan, KG
    Oliveira, MJ
    Seruca, R
    Gallinger, S
    Caldas, C
    Huntsman, D
    [J]. JOURNAL OF MEDICAL GENETICS, 2004, 41 (07) : 508 - 517
  • [9] Caldas C, 1999, J MED GENET, V36, P873
  • [10] Model of the early development of diffuse gastric cancer in E-cadherin mutation carriers and its implications for patient screening
    Carneiro, F
    Huntsman, DG
    Smyrk, TC
    Owen, DA
    Seruca, R
    Pharoah, P
    Caldas, C
    Sobrinho-Simoes, M
    [J]. JOURNAL OF PATHOLOGY, 2004, 203 (02) : 681 - 687